Ivacaftor 150mg tablets
NHS hospitals in England used £447,556,500 of indicative cost of Ivacaftor 150mg tablets in the 12 months to April 2026, about 1.8% of all hospital medicines spend. That is down 8.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ivacaftor 150mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ivacaftor 150mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £50,279,500 |
| Manchester University Nhs Ft | £47,046,750 |
| Leeds Teaching Hpls Nhs Trust | £31,969,000 |
| Royal Papworth Hospital Nhs Ft | £27,069,000 |
| Liverpool Heart & Chest Hosp Found Trust | £24,171,000 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £22,902,250 |
| Univ Hpls Bristol Nhs Foundation Trust | £21,565,250 |
| University Hospital Southampton Nhs Ft | £21,441,000 |
| Nottingham University Hospitals Trust | £19,200,000 |
| King's College Hpl Nhs Foundation Trust | £18,812,500 |
The primary-care picture
Ivacaftor is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ivacaftor medicine page.